Gene Salkind - 30 Jun 2022 Form 4 Insider Report for Mobiquity Technologies, Inc. (MOBQ)

Role: Director, 10%+ Owner
Signature: /s/ Gene Salkind
Issuer symbol: MOBQ
Transactions as of: 30 Jun 2022
Net transactions value: +$510,000
Form type: 4
Filing time: 05 Jul 2022, 21:34:42 UTC
Previous filing: 01 Apr 2022
Next filing: 17 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MOBQ	Common Stock	Conversion of derivative security	$510,000	+408,000	+16%	$1.25	2,992,354	30 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MOBQ	Notes	Conversion of derivative security		-510,000	-100%		0	30 Jun 2022	Common Stock	510,000	$1.25	Direct	F1, F2, F3, F4
transaction	MOBQ	Warrants	Conversion of derivative security		+204,000	+16%		1,441,500	30 Jun 2022	Common Stock	204,000	$4.00	Direct	F1, F2, F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The 2,992,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust.
F2	The board of directors of the issuer accepted Dr. Salkind's offer to convert $510,000 of convertible notes at a reduced conversion price of $1.25 per share into 408,000 common shares and warrants to purchase 204,000 shares at an exercise price of $4.00 per share through September 30, 2029.
F3	Not applicable.
F4	Left blank intentionally.
F5	1,441,500 derivative securities include the following: (i) 390,625 common stock purchase warrants exercisable at $4.00 per share through September 2023; (ii) 10-year options to purchase 35,000 shares granted on December 8, 2021; and (iii) warrants to purchase 1,015,875 shares exercisable through September 30, 2029 which were issuable on June 30, 2022 as a result of the note conversion.